Astellas Pharma Inc. ADR (ALPMY)
Market Closed
15 Dec, 20:00
OTC PINK OTC PINK Primary $
13. 53
+0.48
+3.68%
$
17.76B Market Cap
- P/E Ratio
0.88% Div Yield
4,995 Volume
- Eps
$ 13.05
Previous Close Day Range
13.49 13.6
Year Range
8.37 13.69
Want to track ALPMY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 49 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| ALPMY Astellas Pharma Inc. ADR 4 Feb 2026 (In 1 month) | | 0.22 | - |
| ALPMY Astellas Pharma Inc. ADR 2 Feb 2026 (In 1 month) | | - | - |
| ALPMY Astellas Pharma Inc. ADR 30 Oct 2025 | | 0.16 | 0.3 |
| ALPMY Astellas Pharma Inc. ADR 28 Oct 2025 | | 0.16 | - |
| ALPMY Astellas Pharma Inc. ADR 29 Jul 2025 | | - | - |
| ALPMY Astellas Pharma Inc. ADR 23 Apr 2025 | | - | - |
| ALPMY Astellas Pharma Inc. ADR 2 Feb 2025 | | - | - |
| ALPMY Astellas Pharma Inc. ADR 30 Oct 2024 | | - | - |
| ALPMY Astellas Pharma Inc. ADR 29 Jul 2024 | | - | - |
| ALPMY Astellas Pharma Inc. ADR 20 Jun 2024 | | 0.09 | - |
| ALPMY Astellas Pharma Inc. ADR 24 Apr 2024 | | 0.09 | - |
| ALPMY Astellas Pharma Inc. ADR 5 Feb 2024 | | 0.11 | 0.07 |
| ALPMY Astellas Pharma Inc. ADR 1 Nov 2023 | | 0.18 | - |
| ALPMY Astellas Pharma Inc. ADR 27 Oct 2016 | | - | 0.22 |
| ALPMY Astellas Pharma Inc. ADR 30 Sep 2016 | | - | 0.22 |
| ALPMY Astellas Pharma Inc. ADR 30 Jun 2016 | | - | 0.3 |
| ALPMY Astellas Pharma Inc. ADR 31 Mar 2016 | | - | 0.12 |
| ALPMY Astellas Pharma Inc. ADR 31 Dec 2015 | | - | 0.24 |
| ALPMY Astellas Pharma Inc. ADR 30 Sep 2015 | | - | 0.22 |
| ALPMY Astellas Pharma Inc. ADR 30 Jun 2015 | | - | 0.17 |
| ALPMY Astellas Pharma Inc. ADR 31 Mar 2015 | | - | 0.08 |
| ALPMY Astellas Pharma Inc. ADR 31 Dec 2014 | | - | 0.17 |
| ALPMY Astellas Pharma Inc. ADR 30 Sep 2014 | | - | 0.14 |
| ALPMY Astellas Pharma Inc. ADR 30 Jun 2014 | | - | 0.16 |
| ALPMY Astellas Pharma Inc. ADR 31 Mar 2014 | | - | 0.04 |
| ALPMY Astellas Pharma Inc. ADR 31 Dec 2013 | | - | 0.14 |
| ALPMY Astellas Pharma Inc. ADR 30 Sep 2013 | | - | 0.12 |
| ALPMY Astellas Pharma Inc. ADR 30 Jun 2013 | | - | 0.1 |
| ALPMY Astellas Pharma Inc. ADR 31 Mar 2013 | | - | - |
ALPMY Earnings Reports FAQ
What is the earnings per share (EPS) for ALPMY?
EPS data for ALPMY is currently not available, as Astellas Pharma Inc. ADR has not reported recent earnings.
What is the company's earnings growth rate?
Over the past 12 years, the earnings growth rate has been approximately 9.68%, reflecting the ALPMY's performance and OTC PINK market conditions.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-02, based on the ALPMY's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings were 0.2988 per share, reported on 2025-10-30. For dividend history, visit the ALPMY Dividends page.
What is the price-to-earnings (P/E) ratio?
The price-to-earnings (P/E) ratio is 45.28, calculated based on the most recent stock price of $13.53.
2025 © Marketlog. All Rights Reserved.
